Publicacións en colaboración con investigadores/as de Hospital Vall d'Hebron (21)

2024

  1. Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes—Results from a Multi-Center International Prospective Registry (HOPE-2)

    Journal of Clinical Medicine, Vol. 13, Núm. 9

  2. Spanish cardiac catheterization and coronary intervention registry. 33rd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2023)

    Revista Espanola de Cardiologia, Vol. 77, Núm. 11, pp. 936-946

2023

  1. Coronary angiography in patients without ST-segment elevation following out-of-hospital cardiac arrest. COUPE clinical trial

    Revista Espanola de Cardiologia, Vol. 76, Núm. 2, pp. 94-102

  2. Hydroxychloroquine and Mortality in SARS-Cov-2 Infection; the HOPE-Covid-19 Registry

    Anti-Infective Agents, Vol. 21, Núm. 2, pp. 66-78

  3. Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2)

    Journal of Clinical Medicine, Vol. 12, Núm. 2

2022

  1. Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: The SUGAR trial

    European Heart Journal, Vol. 43, Núm. 13, pp. 1320-1330

2021

  1. Differences in in-hospital mortality after STEMI versus NSTEMI by sex. Eleven-year trend in the Spanish National Health Service

    Revista espanola de cardiologia (English ed.), Vol. 74, Núm. 6, pp. 510-517

2020

  1. Revascularisation in older adult patients with non-ST-segment elevation acute coronary syndrome: effect and impact on 6-month mortality

    European Heart Journal: Acute Cardiovascular Care, Vol. 9, Núm. 4, pp. 358-366

  2. Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) trial: Rationale and study design

    American Heart Journal, Vol. 222, pp. 174-182

2018

  1. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents

    JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991

2016

  1. Occupational eye lens doses in interventional cardiology. A multicentric study

    Journal of Radiological Protection, Vol. 36, Núm. 1, pp. 133-143

2015

  1. Actualización en cardiopatía isquémica y cuidados críticos cardiológicos

    Revista Espanola de Cardiologia, Vol. 68, Núm. 3, pp. 234-241

  2. Cost-effectiveness of a European ST-segment elevation myocardial infarction network: Results from the Catalan Codi Infart network

    BMJ Open, Vol. 5, Núm. 12

  3. Prognosis and management of acute coronary syndrome in Spain in 2012: The DIOCLES study

    Revista Espanola de Cardiologia, Vol. 68, Núm. 2, pp. 98-106

  4. Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis)

    EuroIntervention, Vol. 11, Núm. 3, pp. 336-342

2013

  1. Actualización en cardiopatía isquémica y cuidados críticos cardiológicos

    Revista Espanola de Cardiologia, Vol. 66, Núm. 3, pp. 198-204

2012

  1. Update on ischemic heart disease

    Revista Espanola de Cardiologia, Vol. 65, Núm. SUPPL. 1, pp. 42-49

2011

  1. Actualización en cardiopatía isquémica

    Revista Espanola de Cardiologia, Vol. 64, Núm. SUPPL. 1, pp. 50-58

  2. Evidencias de la revascularización en el infarto agudo de miocardio

    Revista Espanola de Cardiologia Suplementos, Vol. 11, Núm. 3, pp. 9-14

  3. Evidencias de la revascularización en el infarto agudo de miocardio

    Revista Espanola de Cardiologia Suplementos, Vol. 11, Núm. SUPPL. 3, pp. 9-14